US Stock MarketDetailed Quotes

CRVO CervoMed

Watchlist
  • 19.010
  • -0.430-2.21%
Close May 22 16:00 ET
156.90MMarket Cap-49634P/E (TTM)

CervoMed Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.93%-1.42M
-189.57%-7.45M
-266.55%-2.54M
-60.58%2.7M
-53.03%-6.13M
68.67%-1.48M
82.26%-2.57M
77.11%-692.53K
330.67%6.86M
-20.43%-4.01M
Net income from continuing operations
-370.55%-2.51M
62.57%-2.17M
-54.67%-2.36M
44.01%6.4M
-35.33%-5.67M
88.20%-534.34K
75.92%-5.8M
56.04%-1.53M
136.41%4.44M
-10.92%-4.19M
Operating gains losses
----
----
----
----
----
----
-98.53%127.52K
--0
----
----
Change In working capital
642.41%872.45K
-168.79%-261.36K
-354.72%-341.03K
107.88%1.61M
-2,083.66%-1.37M
65.61%-160.85K
6.61%379.94K
14.67%133.88K
-8.43%776.74K
-148.58%-62.93K
-Change in receivables
--915.4K
---915.4K
----
----
----
----
--0
----
----
----
-Change in prepaid assets
81.53%-116.33K
-1,510.21%-1.2M
1,422.06%348.92K
-521.05%-966.4K
-87.55%47.05K
-26.98%-629.71K
134.18%85.1K
79.69%-26.39K
33.45%229.52K
198.46%377.88K
-Change in payables and accrued expense
-182.49%-499.1K
528.90%1.85M
381.99%772.51K
271.70%2.03M
-253.31%-1.56M
2,049.73%605.06K
-51.30%294.83K
-35.02%160.27K
-19.08%547.22K
-15,170.36%-440.81K
-Change in other working capital
520.33%572.48K
----
----
----
----
---136.2K
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
3.93%-1.42M
-189.57%-7.45M
-266.55%-2.54M
-60.58%2.7M
-53.03%-6.13M
68.67%-1.48M
82.26%-2.57M
77.11%-692.53K
330.67%6.86M
-20.43%-4.01M
Investing cash flow
Cash flow from continuing investing activities
100.59K
Net investment purchase and sale
----
----
----
----
----
----
----
----
----
--100.59K
Cash from discontinued investing activities
Investing cash flow
----
----
----
----
----
----
----
----
----
--100.59K
Financing cash flow
Cash flow from continuing financing activities
11.15M
-93.38K
224,949.78%11.24M
0
0
-5K
0
Net common stock issuance
----
--810K
--0
----
----
----
--0
--0
----
----
Net preferred stock issuance
----
----
----
----
----
----
----
----
----
--0
Net other financing activities
----
--10.34M
---93.38K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
----
--11.15M
---93.38K
224,949.78%11.24M
----
----
--0
--0
---5K
--0
Net cash flow
Beginning cash position
90.37%7.79M
-38.59%4.09M
117.81%10.42M
151.43%15M
-73.55%2.61M
-89.03%4.09M
-64.00%6.67M
-88.13%4.79M
-86.22%5.97M
-78.83%9.87M
Current changes in cash
3.93%-1.42M
243.79%3.7M
-280.03%-2.63M
-95.10%1.45M
263.00%6.37M
94.60%-1.48M
-113.69%-2.57M
77.08%-692.53K
1,091.33%29.47M
-17.41%-3.91M
End cash Position
143.88%6.37M
90.37%7.79M
90.37%7.79M
117.81%10.42M
151.43%15M
-73.55%2.61M
-89.03%4.09M
-89.03%4.09M
-88.13%4.79M
-86.22%5.97M
Free cash flow
3.93%-1.42M
-189.57%-7.45M
-266.55%-2.54M
-60.58%2.7M
-53.03%-6.13M
68.67%-1.48M
82.26%-2.57M
77.11%-692.53K
330.67%6.86M
-20.43%-4.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.93%-1.42M-189.57%-7.45M-266.55%-2.54M-60.58%2.7M-53.03%-6.13M68.67%-1.48M82.26%-2.57M77.11%-692.53K330.67%6.86M-20.43%-4.01M
Net income from continuing operations -370.55%-2.51M62.57%-2.17M-54.67%-2.36M44.01%6.4M-35.33%-5.67M88.20%-534.34K75.92%-5.8M56.04%-1.53M136.41%4.44M-10.92%-4.19M
Operating gains losses -------------------------98.53%127.52K--0--------
Change In working capital 642.41%872.45K-168.79%-261.36K-354.72%-341.03K107.88%1.61M-2,083.66%-1.37M65.61%-160.85K6.61%379.94K14.67%133.88K-8.43%776.74K-148.58%-62.93K
-Change in receivables --915.4K---915.4K------------------0------------
-Change in prepaid assets 81.53%-116.33K-1,510.21%-1.2M1,422.06%348.92K-521.05%-966.4K-87.55%47.05K-26.98%-629.71K134.18%85.1K79.69%-26.39K33.45%229.52K198.46%377.88K
-Change in payables and accrued expense -182.49%-499.1K528.90%1.85M381.99%772.51K271.70%2.03M-253.31%-1.56M2,049.73%605.06K-51.30%294.83K-35.02%160.27K-19.08%547.22K-15,170.36%-440.81K
-Change in other working capital 520.33%572.48K-------------------136.2K----------------
Cash from discontinued investing activities
Operating cash flow 3.93%-1.42M-189.57%-7.45M-266.55%-2.54M-60.58%2.7M-53.03%-6.13M68.67%-1.48M82.26%-2.57M77.11%-692.53K330.67%6.86M-20.43%-4.01M
Investing cash flow
Cash flow from continuing investing activities 100.59K
Net investment purchase and sale --------------------------------------100.59K
Cash from discontinued investing activities
Investing cash flow --------------------------------------100.59K
Financing cash flow
Cash flow from continuing financing activities 11.15M-93.38K224,949.78%11.24M00-5K0
Net common stock issuance ------810K--0--------------0--0--------
Net preferred stock issuance --------------------------------------0
Net other financing activities ------10.34M---93.38K----------------------------
Cash from discontinued financing activities
Financing cash flow ------11.15M---93.38K224,949.78%11.24M----------0--0---5K--0
Net cash flow
Beginning cash position 90.37%7.79M-38.59%4.09M117.81%10.42M151.43%15M-73.55%2.61M-89.03%4.09M-64.00%6.67M-88.13%4.79M-86.22%5.97M-78.83%9.87M
Current changes in cash 3.93%-1.42M243.79%3.7M-280.03%-2.63M-95.10%1.45M263.00%6.37M94.60%-1.48M-113.69%-2.57M77.08%-692.53K1,091.33%29.47M-17.41%-3.91M
End cash Position 143.88%6.37M90.37%7.79M90.37%7.79M117.81%10.42M151.43%15M-73.55%2.61M-89.03%4.09M-89.03%4.09M-88.13%4.79M-86.22%5.97M
Free cash flow 3.93%-1.42M-189.57%-7.45M-266.55%-2.54M-60.58%2.7M-53.03%-6.13M68.67%-1.48M82.26%-2.57M77.11%-692.53K330.67%6.86M-20.43%-4.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg